CRISPR/Cas9 for hepatitis B virus infection treatment
Abstract Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibit viral replication, slow the progression of liver fibrosis...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2023-05-01
|
| Serija: | Immunity, Inflammation and Disease |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/iid3.866 |
| Oznake: |
Brez oznak, prvi označite!
|